Verrica Pharmaceuticals Inc

XNAS:VRCA 4:00:00 PM EDT

8.31

+0.01 (+0.12%)

5:24:19 PM EDT: $8.20 -0.11 (-1.32%)

Market Cap (Intraday)	78.96M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.53 Million
Adjusted EPS	-$0.81

See more estimates

10-Day MA	$8.19
50-Day MA	$5.95
200-Day MA	$5.65

See more pivots

Verrica Pharmaceuticals Inc Stock, XNAS:VRCA

44 West Gay Street, Suite 400, West Chester, Pennsylvania 19380

United States of America

Phone: +1.434.453.3300

Number of Employees: 71

http://www.verrica.com

Description

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.